Vaccine News and Research

Latest Vaccine News and Research

Restricting air travel as good as useless when it comes to stopping bird flu

According to British researchers attempts to halt a flu pandemic by restricting air travel will have little effect and even in the best case scenario the speediest action will serve to delay it by only a few months.

3 May 2006

SLU Liver Center to study effectiveness of tenofovir in treating hepatitis B

Saint Louis University School of Medicine researchers are studying the effectiveness of a drug for patients with chronic hepatitis B that is currently used to treat HIV.

3 May 2006

Saint Louis University hunt for a Hepatitis C vaccine

Human clinical trials involving investigational vaccines to prevent Hepatitis C are rare. In the fall of 2003 there was a first-ever study at Saint Louis University Center for Vaccine Development, and an earlier small study at Johns Hopkins School of Medicine.

3 May 2006

More effective influenza vaccine

An intranasal influenza vaccine proved to be more effective than the injectable influenza vaccine in children older than 6 months and younger than 5 years of age, according to study data presented at the annual meeting of the Pediatric Academic Societies in San Francisco.

3 May 2006

Scientists discover a master key to microbes' pathogenic lifestyles

For some microbes, the transformation from a benign lifestyle in the soil to that of a potentially deadly human pathogen is just a breath away.

3 May 2006

New vaccine against lethal avian influenza virus shows promise

A commercially developed vaccine has successfully protected mice and ferrets against a highly lethal avian influenza virus, according to the investigator who led the study at St. Jude Children's Research Hospital.

3 May 2006

South East Asia could be the epicentre of the next human influenza pandemic

The Asia-Pacific region faces a number of challenges in preparing for an influenza pandemic, yet gaps and inconsistencies in plans across the continent could hinder an effective response to a pandemic, according to a new report presented at the Lancet Asia Medical Forum 2006, Singapore.

3 May 2006

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax

Anthrax vaccine administered in combination with a short course of antibiotics completely protected nonhuman primates from inhalational anthrax, the most lethal form of the disease, according to scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

3 May 2006

Nasal flu spray offers best protection for babes and toddlers

According to one of the largest comparisons of flu vaccines ever carried out, spraying a flu vaccine into the noses of babies and preschoolers is a far more effective method of protecting them than injections.

2 May 2006

Study investigates early biology of HIV infection

In July 2005, the race to find a vaccine that would stem the worldwide rate of 13,000 new cases of HIV infection each day moved from competition among research institutions to a strategy of cooperation.

2 May 2006

Combo of testing and vaccines a winner in fight against cervical cancer

According to experts in reproductive health, the combination of HPV testing with HPV vaccines is the best hope for preventing cervical cancer.

1 May 2006

Combinatorial approach found to reverse the onset of type 1 diabetes

A major finding, which represents an important step toward a potential cure for type 1 (insulin-dependent) diabetes, has been made by a research team at the La Jolla Institute for Allergy & Immunology (LIAI). The team, led by Matthias von Herrath, M.D., an internationally recognized expert on the molecular basis of type 1 diabetes, used a combinatorial treatment approach in laboratory mice and found it reversed recent onset type 1 diabetes in the majority of animals tested.

28 Apr 2006

Potential vaccine for visceral leishmaniasis developed

Development of a fundamentally new "candidate," or potential, vaccine for visceral leishmaniasis (LEASH-ma-NIGH-a-sis), a parasitic disease that kills about 60,000 people annually, is reported in the current issue of ACS Chemical Biology. Spread by the bite of infected female sand flies, visceral leishmaniasis infects about 500,000 people annually, with the majority of cases occurring in India, Bangladesh, Nepal, Sudan and Brazil.

26 Apr 2006

European flu pandemic plans show gaps and inconsistencies

A report reveals marked discrepancies in pandemic preparedness across Europe. The authors conclude that further planning and implementation is needed so that governments can effectively respond in the event of a pandemic, recommending action by the European Union to ensure governments work together towards a coordinated approach.

26 Apr 2006

Avian flu vaccine to be developed by Mount Sinai School of Medicine and Bionostra

The Mount Sinai School of Medicine will collaborate with the prestigious Bionostra Group of Spain to develop an avian flu vaccine. The vaccine will protect against the lethal infection of the H5N1 virus.

26 Apr 2006

Birth defects from rubella almost eradicated in the USA

Congenital rubella syndrome, a birth defect caused by the rubella virus (also known as German measles), has practically been eliminated in the U.S., according to a statement published in the April 2006 issue of Birth Defects Research Part A, the official journal of The Teratology Society.

23 Apr 2006

Novel approach used to neutralize anthrax toxin

Researchers from Rensselaer Polytechnic Institute and the University of Toronto have designed a nanoscale assembly of molecules that successfully counteracts and inhibits anthrax toxin in animal and laboratory experiments.

23 Apr 2006

Drug combo might beat type 1 diabetes

Scientists in California have developed a cocktail of drugs which can reverse diabetes and say the discovery is an important step towards a potential cure.

23 Apr 2006

Australian scientists tackle deadly Q fever

Scientists at James Cook University have taken the lead in developing a new vaccine against a highly infectious cattleyard disease caused by a bacteria which has the potential to be developed as a bioterrorist weapon.

20 Apr 2006

National Autism Association points out possible conflicts of interest in new study denying epidemic rise in autism rates

A study published in Pediatrics, "The Contribution of Diagnostic Substitution to the Growing Administrative Prevalence of Autism in US Special Education," suggests that autism diagnoses haven't actually risen over the past two decades, despite growing and credible scientific evidence to the contrary.

19 Apr 2006